Idecabtagene vicleucel is well tolerated and effective in relapsed/refractory myeloma patients with prior allogeneic stem cell transplantation - John, Lukas; Sauer, Sandra; Hegenbart, Ute; Dreger, Peter; Hundemer, Michael; Müller-Tidow, Carsten; Schmitt, Anita; Schmitt, Michael; Raab, Marc-Steffen; Schönland, Stefan (Transplantation and cellular therapy, 2023)
Online verfügbar 20 June 2023, Version des Artikels 11 October 2023